United Research Laboratories andMutual Pharmaceutical Company today announce that Mutual has filed anAbbreviated New Drug Application (ANDA) with the Food and DrugAdministration (FDA), seeking approval to market Mutual's guaifenesinextended-release tablets, 600 mg and 1200 mg. Guaifenesin extended-releasetablets are currently marketed over-the-counter by Adams RespiratoryTherapeutics under the brand name Mucinex(R). [click link for full article]
(more...)